Automated transfer station at SiO2 in Auburn Two top federal biological research agencies today announced an agreement investing $142 million in an Auburn biotech to speed production of specially engineered vials for coronavirus vaccines. The Department of Defense’s Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense, along with…
